Abstract
Parkinson’s disease (PD) is a neurodegenerative disease, which has an upward progression. In advanced stages, motor symptoms cause functional impairment to patients due to the degeneration of the substantia nigra. In early stages of PD, there is a sensory impairment, and patients report visual processing dysfunction. There is still no cure for PD, and early diagnosis is essential to slow disease progression. Given the good anatomical representation and organization of the visual system in the cerebral cortex, in this study, we propose a biomarker of PD using EEG signals, photic stimulation, partial directed coherence (PDC) to perform feature extraction, and machine learning (ML) techniques. Our goal is to classify participants into three distinct groups: PD patients who are medicated; patients with PD and drug deprivation; and healthy subjects. We were able to achieve outstanding results, above 99% of accuracy and kappa statistic up to 0.98 using random forests and feature selection techniques. Comparison with existing methods: Our approach was evaluated using several ML methods. As features, we initially used the electrodes, without explicitly extracting feature vectors over signal samples. The good results we obtained by using random forests made possible clinical applications for the early detection of PD and, consequently, better prognosis and patient’s quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.